news

Life Sciences - Health - 27.09.2023

First experimental study to propose a therapy to correct memory deficit caused by disorders in the fetal alcohol spectrum
Research conducted in a mouse model identifies the neurobiological mechanism responsible for alterations in the memory of young individuals exposed to alcohol during pregnancy and lactation. This study proposes a therapy that can reverse the deficit, paving the way for treating a disorder that is underdiagnosed in humans.

Health - 22.09.2023

Decoded the cellular and molecular mechanisms of Asherman’s syndrome, a rare disease that leaves women without menstruation
An article published by the full professor of the Department of Paediatrics, Obstetrics and Gynaecology of the University of Valencia (UV) Carlos Simón and his research team (UV, INCLIVA and Carlos Simón Foundation) in the journal Nature Communications , describes for the first time the cellular alterations responsible for Asherman's Syndrome at the single cell level.

Life Sciences - Health - 21.09.2023

Rosario Gil: ’In Valencia we are developing a system to fight the tiger mosquito plague with the bacterium Wolbachia ’
Rosario Gil: "In Valencia we are developing a system to fight the tiger mosquito plague with the bacterium Wolbachia " Rosario Gil García is a professor at the University of Valencia (UV) in the Department of Genetics and a researcher at the Institute of Integrative Systems Biology (I2SysBio), a joint centre of the UV and the Spanish National Research Council (CSIC).

Life Sciences - Health - 12.09.2023

Reducing the population of the Asian tiger mosquito in Valencia by inoculating males with the Wolbachia bacteria investigated
Reducing the population of the Asian tiger mosquito in Valencia by inoculating males with the Wolbachia bacteria investigated A team of researchers from the University of Valencia (UV) is working on

Life Sciences - Health - 07.09.2023

Pioneering research by the University of Valencia and the CSIC uses bacteria viruses against Xylella fastidiosa in the Balearic Islands
Pioneering research by the University of Valencia and the CSIC uses bacteria viruses against Xylella fastidiosa in the Balearic Islands Pilar Domingo-Calap, researcher at the Institute of Integrative Systems Biology (I2SysBio), a joint centre of the University of Valencia (UV) and the Spanish National Research Council (CSIC), directs research with phages (bacterial viruses) that has started treating crop plants affected by the bacteria Xylella fastidiosa in the Balearic Islands.

Life Sciences - Health - 06.09.2023

HIV drug may be used to treat Alzheimer’s disease
Researchers from the Autonomous University of Madrid (UAM) and CSIC have studied the effect of lamivudine, a drug used in the treatment of HIV, in a transgenic model of Alzheimer's disease. The results, published in the International Journal of Molecular Sciences , suggest that retranscriptase inhibitors may be a promising strategy to be developed in the field of neurodegenerative diseases.

Health - Environment - 05.09.2023

The UPF Genomics Service analyses the DNA of the bone remains of three skeletons, one of which may belong to Pere d’Aragó i d’Anjou (Peter of Aragon)
Empowering Europe against infectious diseases: innovative framework to tackle climate-driven health risks Empowering Europe against infectious diseases: innovative framework to tackle climate-driven h

Health - Computer Science - 31.07.2023

Deep learning method developed to understand how chronic pain affects each patient’s body
A research team from the Universidad Carlos III de Madrid (UC3M), together with University College London in the United Kingdom, has carried out a study to analyse how chronic pain affects each patient's body. Within this framework, a deep learning method has been developed to analyse the biometric data of people with chronic conditions.

Health - Pharmacology - 17.07.2023

Researchers study the effects of cytomegalovirus in the blood of patients with CAR-T therapies against some cancers
Researchers from the University of Valencia and the INCLIVA Health Research Institute (Valencia Clinical Hospital) have analysed the possible effects of the presence of cytomegalovirus (CMV) in the blood of patients receiving CAR-T therapies, a form of immunotherapy that has been shown to be effective in certain types of haematological cancer.

Life Sciences - Health - 05.07.2023

Bacteria of pharmaceutical interest in sea slugs for the first time
An international research team in which the Institute for Integrative Systems Biology (I2SysBio), joint centre of the Higher Council for Scientific Research (CSIC) and the University of Valencia (UV) participate, has just published a study in the journal Microbiome which reveals the presence of beta-lactones, a group of little-studied substances with pharmaceutical potential generated by symbiotic bacteria that inhabit the skin of a species of nudibranch, a sea slug.

Pharmacology - Health - 29.06.2023

Culmination of the eTRANSAFE project to share data on the safety of medicines
The project, jointly coordinated by UPF professor Ferran Sanz, has enjoyed the participation of numerous members of the GRIB; the UPF research programme in Medical Bioinformatics and the Hospital del Mar Research Institute, as well as the spinoff Med Bioinformatics Solutions, which emerged from the same programme.

Health - Life Sciences - 26.06.2023

Cooperation between muscle and liver circadian clocks, key to controlling glucose metabolism
An international study on the effect of circadian clocks in different tissues shows that there is a minimal network required for the control of glucose levels in the body. This finding has clear implications for diabetes and other age-related diseases. Collaborative work by teams at the Department of Medicine and Life Sciences ( MELIS ) at Pompeu Fabra University (UPF), University of California, Irvine (UCI), and the Institute for Research in Biomedicine (IRB Barcelona) has shown that interplay between circadian clocks in liver and skeletal muscle controls glucose metabolism.

Health - Social Sciences - 15.05.2023

Research is to compare the health and lifestyles of the population aged 70 to 79 in Lleida and Seville
Aïda Solé-Auró, a professor at the UPF Department of Political and Social Sciences, is joint principal investigator of the project.

Health - Life Sciences - 10.05.2023

One step closer to eliminating latency, the real challenge in combating HIV
An international study coordinated by the MELIS-UPF researchers Andreas Meyerhans and Juana Díez has identified Schlafen 12, a new HIV restriction factor that could pave the way for new strategies for curing the infection. An international study led by MELIS-UPF researchers from the Infection Biology and Molecular Virology laboratories has identified and characterized Schlafen 12 (SLFN 12) as a novel HIV restriction factor.

Health - 09.05.2023

37% of Valenbisi users maintained their mobility routine during the COVID-19 pandemic
Research from the University of Valencia (UV) shows that 37% of users of the shared bicycle service (Valenbisi) maintained their mobility routine during the COVID-19 pandemic.

Health - Innovation - 04.05.2023

The University of Valencia participates in a project that combats foodborne illnesses with artificial intelligence and personalised nutrition
Dolors Corella, professor of the Department of Preventive Medicine and Public Health of the University of Valencia, participates in the European CoDiet project, in which seventeen academic and resear

Health - Computer Science - 26.04.2023

Custom surgical guides developed with artificial intelligence
Researchers from the Universidad Carlos III de Madrid (UC3M) and the startup Digital Anatomics have developed a technological solution for the health field which makes it possible, through artificial intelligence, for complex medical surgeries to be adapted to the particularities of each patient. Digital Anatomics carries out its activity in the UC3M Science Park.

Health - Pharmacology - 19.04.2023

Antonio Cano investigates a drug that reduces menopausal hot flashes
Antonio Cano, full professor of the Department of Paediatrics, Obstetrics and Gynaecology of the University of Valencia and coordinator of the Women's Health Research Group at the INCLIVA Health Research Institute, of the Clinical Hospital of Valencia, participates in an international investigation published in The Lancet magazine that has released the results of the SKYLIGHT 1 clinical trial.

Life Sciences - Health - 29.03.2023

Juan Nácher: ’It has been proved that cannabis is a risk factor for the development of schizophrenia’
Juan Nácher Roselló, full professor of Cellular Biology at the University of Valencia (UV), is one of the main researchers of the Spanish Network for Cooperative Study in Mental Health (CIBERSAM), as

Health - Pharmacology - 27.03.2023

Non-invasive localisation of breast lesions for surgical planning
A research group from the Universidad Carlos III de Madrid (UC3M) has participated in the development of a new technique based on medical imaging which makes it possible to non-invasively estimate the location of a tumour in the surgical position required for breast cancer surgery.